Psiquiatria

Next-Step Treatment Options for Treatment-Resistant Depression: Insights From the Mayo Clinic Depression Center Panel.

The Journal of clinical psychiatry. 2026 Jan; 87(Jan):doi: 10.4088/JCP.25cs16066. pii: 25cs16066.

Recent Pharmacological Guidelines for Difficult-to-Treat Mental Disorders.

Journal of psychosocial nursing and mental health services. 2026 May; 64(May):9-12. doi: 10.3928/02793695-20260414-02. pii: .

Changes in Genetic Contributions to ASD and ADHD by Year of Diagnosis.

JAMA psychiatry. 2026 Jun; doi: 10.1001/jamapsychiatry.2026.1450. pii: .

Cannabis and Mental Health: A Review.

JAMA internal medicine. 2026 May; 186(May):618-628. doi: 10.1001/jamainternmed.2025.8215. pii: .

Pharmacological Management of ADHD in Women Across Perimenopause, Menopause and Post-Menopause.

Drugs & aging. 2026 Apr; doi: 10.1007/s40266-026-01291-z. pii: .

Beliefs about the biological nature of mental disorders and how they affect antidepressant use and withdrawal.

Journal of affective disorders. 2026 May; 400(May):121069. doi: 10.1016/j.jad.2025.121069. pii: S0165-0327(25)02511-X.

The pharmacological rationale for amiloride nasal spray: potentially a portable and rapid-acting treatment for panic disorder.

The British journal of psychiatry : the journal of mental science. 2026 Jun; 228(Jun):557-561. doi: 10.1192/bjp.2026.10611. pii: .

New approaches to clinical research for people with schizophrenia.

The British journal of psychiatry : the journal of mental science. 2026 May; 1-4. doi: 10.1192/bjp.2026.10657. pii: .

Advances in schizophrenia research and treatment: exploring neurotransmitter imbalances, genetics, and innovative therapies.

Progress in neuro-psychopharmacology & biological psychiatry. 2026 May; 147(May):111749. doi: 10.1016/j.pnpbp.2026.111749. pii: S0278-5846(26)00146-6.

Treatment trials for negative symptoms in schizophrenia.

Current opinion in psychiatry. 2026 May; 39(May):216-221. doi: 10.1097/YCO.0000000000001067. pii: .

Clozapine treatment in the early stages of schizophrenia.

Current opinion in psychiatry. 2026 May; 39(May):209-215. doi: 10.1097/YCO.0000000000001059. pii: .

Loneliness and psychosis: an integrative review.

Current opinion in psychiatry. 2026 May; 39(May):201-208. doi: 10.1097/YCO.0000000000001058. pii: .

Pharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials.

Acta psychiatrica Scandinavica. 2026 May; 153(May):402-431. doi: 10.1111/acps.70034. pii: .

Corticosteroid-Induced neuropsychiatric manifestations: From pathophysiology to management.

Psychopharmacology. 2026 May; doi: 10.1007/s00213-026-07084-x. pii: .

Treatment of Anxiety for Adults in Primary Care Settings: A Review.

JAMA internal medicine. 2026 May; doi: 10.1001/jamainternmed.2026.0395. pii: .

From DSM-IV to the future: three decades of evolution in psychiatric classification and what lies ahead.

International review of psychiatry (Abingdon, England). 2026 ; 38():27-36. doi: 10.1080/09540261.2025.2523455. pii: .

Updated trends in the global prevalence and burden of mental disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

Lancet (London, England). 2026 May; 407(May):2040-2064. doi: 10.1016/S0140-6736(26)00519-2. pii: S0140-6736(26)00519-2.

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part II: OCD and PTSD.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 2023 Feb; 24(Feb):118-134. doi: 10.1080/15622975.2022.2086296. pii: .

Recommendation on screening adults for depression using a screening tool.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2025 Oct; 197(Oct):E1132-E1143. doi: 10.1503/cmaj.250237. pii: .

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 2023 Feb; 24(Feb):79-117. doi: 10.1080/15622975.2022.2086295. pii: .

Latin American consensus recommendations for the management and treatment of patients with treatment-resistant depression (TRD).

Spanish journal of psychiatry and mental health. 2025 ; 18():208-215. doi: 10.1016/j.sjpmh.2023.06.001. pii: S2950-2853(23)00013-3.

Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Bipolar Type I Disorder: A Consensus Panel Report.

The Journal of clinical psychiatry. 2025 Aug; 86(Aug):doi: 10.4088/JCP.plunlai2424ah3. pii: plunlai2424ah3.

Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Schizophrenia: A Consensus Panel Report.

The Journal of clinical psychiatry. 2025 Aug; 86(Aug):doi: 10.4088/JCP.plunlai2424ah2. pii: plunlai2424ah2.

INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia.

The lancet. Psychiatry. 2025 May; 12(May):384-394. doi: 10.1016/S2215-0366(25)00031-8. pii: S2215-0366(25)00031-8.

Early use of long-acting injectable antipsychotics in bipolar disorder type I: An expert consensus.

Bipolar disorders. 2025 Feb; 27(Feb):7-16. doi: 10.1111/bdi.13498. pii: .

Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper.

European psychiatry : the journal of the Association of European Psychiatrists. 2025 Jan; 68(Jan):e3. doi: 10.1192/j.eurpsy.2024.1806. pii: .

The American Psychiatric Association Practice Guideline for the Treatment of Patients With Borderline Personality Disorder.

The American journal of psychiatry. 2024 Nov; 181(Nov):1024-1028. doi: 10.1176/appi.ajp.24181010. pii: .

Update of the World Health Organization's Mental Health Gap Action Programme Guideline for Psychoses (Including Schizophrenia).

Schizophrenia bulletin. 2024 Nov; 50(Nov):1310-1325. doi: 10.1093/schbul/sbae043. pii: .

Antipsychotic Drugs: A Concise Review of History, Classification, Indications, Mechanism, Efficacy, Side Effects, Dosing, and Clinical Application.

The American journal of psychiatry. 2024 Oct; 181(Oct):865-878. doi: 10.1176/appi.ajp.20240738. pii: .

The clinical utility and relevance in clinical practice of DSM-5 specifiers for major depressive disorder: A Delphi expert consensus study.

Comprehensive psychiatry. 2024 Aug; 133(Aug):152502. doi: 10.1016/j.comppsych.2024.152502. pii: S0010-440X(24)00053-1.

Screening for Depression and Suicide Risk in Adults: US Preventive Services Task Force Recommendation Statement.

JAMA. 2023 Jun; 329(Jun):2057-2067. doi: 10.1001/jama.2023.9297. pii: .

[A consensus report by the Working Group on Eating Disorders of Sociedad Española de Nutrición Clínica y Metabolismo (GTTCA-SENPE). Evaluation, medical and nutritional management of anorexia nervosa. Update 2023].

Nutricion hospitalaria. 2024 Mar; 41(Mar):1-60. doi: 10.20960/nh.05175. pii: .

Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery.

BMC psychiatry. 2023 Jun; 23(Jun):453. doi: 10.1186/s12888-023-04928-0. pii: 453.

The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders.

The American journal of psychiatry. 2023 Feb; 180(Feb):167-171. doi: 10.1176/appi.ajp.23180001. pii: .

Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.

JAMA. 2022 Oct; 328(Oct):1534-1542. doi: 10.1001/jama.2022.16946. pii: .

Efficacy of 5 × 5 accelerated versus conventional repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression.

Journal of affective disorders. 2026 Jun; 403(Jun):121345. doi: 10.1016/j.jad.2026.121345. pii: S0165-0327(26)00196-5.

How do large language models answer ADHD-related questions? A comparative study of ChatGPT, Gemini, and DeepSeek.

BMC psychiatry. 2026 Jun; doi: 10.1186/s12888-026-08280-x. pii: .

Changes in Genetic Contributions to ASD and ADHD by Year of Diagnosis.

JAMA psychiatry. 2026 Jun; doi: 10.1001/jamapsychiatry.2026.1450. pii: .

The pharmacological rationale for amiloride nasal spray: potentially a portable and rapid-acting treatment for panic disorder.

The British journal of psychiatry : the journal of mental science. 2026 Jun; 228(Jun):557-561. doi: 10.1192/bjp.2026.10611. pii: .

Clinical Implications of Autistic Features in Patients With a First Episode of Psychosis.

Acta psychiatrica Scandinavica. 2026 Jun; 153(Jun):636-648. doi: 10.1111/acps.70079. pii: .

Updated trends in the global prevalence and burden of mental disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

Lancet (London, England). 2026 May; 407(May):2040-2064. doi: 10.1016/S0140-6736(26)00519-2. pii: S0140-6736(26)00519-2.

Recovery Processes Reported by People with Severe Mental Illness in Brazil: Systematic Review and Thematic Synthesis.

Transcultural psychiatry. 2026 May; 13634615261445848. doi: 10.1177/13634615261445848. pii: .

Structure of the Genetic Risks for Psychiatric Disorders in Swedish Population-Based Registries.

JAMA psychiatry. 2026 May; doi: 10.1001/jamapsychiatry.2026.1047. pii: .

Advances in schizophrenia research and treatment: exploring neurotransmitter imbalances, genetics, and innovative therapies.

Progress in neuro-psychopharmacology & biological psychiatry. 2026 May; 147(May):111749. doi: 10.1016/j.pnpbp.2026.111749. pii: S0278-5846(26)00146-6.

New approaches to clinical research for people with schizophrenia.

The British journal of psychiatry : the journal of mental science. 2026 May; 1-4. doi: 10.1192/bjp.2026.10657. pii: .